Inflammation, a major contributor to CRC development, was also markedly suppressed by PSO through the inhibition of NF-κB and COX-2 expression, further corroborating its anti-inflammatory and anti-tumorigenic effects. This evidence concerns the gene NFKB1 and colorectal carcinoma.